Search

Your search keyword '"Porphyromonas gingivalis immunology"' showing total 430 results

Search Constraints

Start Over You searched for: Descriptor "Porphyromonas gingivalis immunology" Remove constraint Descriptor: "Porphyromonas gingivalis immunology" Search Limiters Available in Library Collection Remove constraint Search Limiters: Available in Library Collection
430 results on '"Porphyromonas gingivalis immunology"'

Search Results

1. Evaluation of a Novel Immunochromatographic Device for Detecting Porphyromonas gingivalis in Patients with Periodontal Disease.

2. Modulation of allograft immune responses by Porphyromonas gingivalis lipopolysaccharide administration in a rat model of kidney transplantation.

3. Cystatin C: immunoregulation role in macrophages infected with Porphyromonas gingivalis .

4. Differential Response of Human Dendritic Cells upon Stimulation with Encapsulated or Non-Encapsulated Isogenic Strains of Porphyromonas gingivalis .

5. Porphyromonas gingivalis fuels colorectal cancer through CHI3L1-mediated iNKT cell-driven immune evasion.

6. Stimulation phosphatidylinositol 3-kinase/protein kinase B signaling by Porphyromonas gingivalis lipopolysacch aride mediates interleukin-6 and interleukin-8 mRNA/protein expression in pulpal inflammation.

7. Computational Design of a Multi-Epitope Vaccine Against Porphyromonas gingivalis .

8. GDF15 Supports the Inflammatory Response of PdL Fibroblasts Stimulated by P. gingivalis LPS and Concurrent Compression.

9. Extracellular vesicles of P. gingivalis-infected macrophages induce lung injury.

10. STAT1/SOCS1/3 Are Involved in the Inflammation-Regulating Effect of GAS6/AXL in Periodontal Ligament Cells Induced by Porphyromonas gingivalis Lipopolysaccharide In Vitro .

11. Porphyromonas gingivalis induces periodontitis, causes immune imbalance, and promotes rheumatoid arthritis.

12. An Explorative Study on Monocyte Reprogramming in the Context of Periodontitis In Vitro and In Vivo .

13. Uptake of Nanotitania by Gingival Epithelial Cells Promotes Inflammatory Response and Is Accelerated by Porphyromonas gingivalis Lipopolysaccharide: An In Vitro Study.

14. Subversion of Lipopolysaccharide Signaling in Gingival Keratinocytes via MCPIP-1 Degradation as a Novel Pathogenic Strategy of Inflammophilic Pathobionts.

15. Development and Optimization of a Rapid Colorimetric Membrane Immunoassay for Porphyromonas gingivalis .

16. Influence of the shared epitope on the elicitation of experimental autoimmune arthritis biomarkers.

17. Associations of Antibodies Targeting Periodontal Pathogens With Subclinical Coronary, Carotid, and Peripheral Arterial Atherosclerosis in Rheumatoid Arthritis.

18. Sphingolipid-Containing Outer Membrane Vesicles Serve as a Delivery Vehicle To Limit Macrophage Immune Response to Porphyromonas gingivalis.

19. Respiratory FimA-Specific Secretory IgA Antibodies Upregulated by DC-Targeting Nasal Double DNA Adjuvant Are Essential for Elimination of Porphyromonas gingivalis .

20. Porphyromonas gingivalis gingipains potentially affect MUC5AC gene expression and protein levels in respiratory epithelial cells.

21. Microbial Lipid A Remodeling Controls Cross-Presentation Efficiency and CD8 T Cell Priming by Modulating Dendritic Cell Function.

22. In-vivo imaging revealed antigen-directed gingival B10 infiltration in experimental periodontitis.

23. Gastrin-Releasing Peptide (GRP) Stimulates Osteoclastogenesis in Periodontitis.

24. Oral Dysbiosis and Autoimmunity: From Local Periodontal Responses to an Imbalanced Systemic Immunity. A Review.

25. Oral P. gingivalis impairs gut permeability and mediates immune responses associated with neurodegeneration in LRRK2 R1441G mice.

26. Characterization and regulation of osteoclast precursors following chronic Porphyromonas gingivalis infection.

27. Frontline Science: Characterization and regulation of osteoclast precursors following chronic Porphyromonas gingivalis infection.

28. Early host-microbe interaction in a peri-implant oral mucosa-biofilm model.

29. Crosstalk between Akt and NF-κB pathway mediates inhibitory effect of gas6 on monocytes-endothelial cells interactions stimulated by P. gingivalis-LPS.

30. Salvianolic Acid B improves cognitive impairment by inhibiting neuroinflammation and decreasing Aβ level in Porphyromonas gingivalis -infected mice.

31. Identification and Modification of Porphyromonas gingivalis Cysteine Protease, Gingipain, Ideal for Screening Periodontitis.

32. Glycine Lipids of Porphyromonas gingivalis Are Agonists for Toll-Like Receptor 2.

33. Efficacy and safety of PERIOdontal treatment versus usual care for Nonalcoholic liver disease: protocol of the PERION multicenter, two-arm, open-label, randomized trial.

34. Candida albicans Shields the Periodontal Killer Porphyromonas gingivalis from Recognition by the Host Immune System and Supports the Bacterial Infection of Gingival Tissue.

35. A Uniquely Altered Oral Microbiome Composition Was Observed in Pregnant Rats With Porphyromonas gingivalis Induced Periodontal Disease.

36. Association of rheumatoid arthritis disease activity and antibodies to periodontal bacteria with serum lipoprotein profile in drug naive patients.

37. Halofuginone functions as a therapeutic drug for chronic periodontitis in a mouse model.

38. The Distinct Immune-Stimulatory Capacities of Porphyromonas gingivalis Strains 381 and ATCC 33277 Are Determined by the fimB Allele and Gingipain Activity.

39. Increased Heart Failure Prevalence in Patients with a High Antibody Level Against Periodontal Pathogen.

40. Fetal Weight Outcomes in C57BL/6J and C57BL/6NCrl Mice after Oral Colonization with Porphyromonas gingivalis .

41. Linkage of Periodontitis and Rheumatoid Arthritis: Current Evidence and Potential Biological Interactions.

42. Distinct gene expression characteristics in epithelial cell- Porphyromonas gingivalis interactions by integrating transcriptome analyses.

43. Inflammatory arthritis disrupts gut resolution mechanisms, promoting barrier breakdown by Porphyromonas gingivalis.

44. Serum Levels of Interleukin-6 and Titers of Antibodies Against Porphyromonas gingivalis Could Be Potential Biomarkers for the Diagnosis of Oral Squamous Cell Carcinoma.

45. Th1-type immune responses to Porphyromonas gingivalis antigens exacerbate angiotensin II-dependent hypertension and vascular dysfunction.

46. Oral Administration of Porphyromonas gingivalis , a Major Pathogen of Chronic Periodontitis, Promotes Resistance to Paclitaxel in Mouse Xenografts of Oral Squamous Cell Carcinoma.

47. Triggering NETosis via protease-activated receptor (PAR)-2 signaling as a mechanism of hijacking neutrophils function for pathogen benefits.

48. BET Bromodomain Inhibitors Suppress Inflammatory Activation of Gingival Fibroblasts and Epithelial Cells From Periodontitis Patients.

49. TET1 Knockdown Inhibits Porphyromonas gingivalis LPS/IFN-γ-Induced M1 Macrophage Polarization through the NF-κB Pathway in THP-1 Cells.

50. Functionality of the Interleukin 8 haplotypes in lymphocytes and macrophages in response to gram-negative periodontopathogens.

Catalog

Books, media, physical & digital resources